Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Revenue: 2021-2024

Historic Revenue for Immunocore Holdings (IMCR) over the last 4 years, with Dec 2024 value amounting to $310.2 million.

  • Immunocore Holdings' Revenue rose 29.22% to $103.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $379.6 million, marking a year-over-year increase of 28.10%. This contributed to the annual value of $310.2 million for FY2024, which is 24.37% up from last year.
  • Immunocore Holdings' Revenue amounted to $310.2 million in FY2024, which was up 24.37% from $249.4 million recorded in FY2023.
  • Over the past 5 years, Immunocore Holdings' Revenue peaked at $310.2 million during FY2024, and registered a low of $36.5 million during FY2021.
  • Over the past 3 years, Immunocore Holdings' median Revenue value was $249.4 million (recorded in 2023), while the average stood at $244.7 million.
  • Data for Immunocore Holdings' Revenue shows a peak YoY spiked of 377.91% (in 2022) over the last 5 years.
  • Over the past 4 years, Immunocore Holdings' Revenue (Yearly) stood at $36.5 million in 2021, then spiked by 377.91% to $174.4 million in 2022, then spiked by 43.05% to $249.4 million in 2023, then rose by 24.37% to $310.2 million in 2024.